Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.
about
COPD exacerbation: lost in translationModels of chronic obstructive pulmonary diseaseATP-binding cassette (ABC) transporters in normal and pathological lungFine particulate matter in acute exacerbation of COPDExhaled Breath Condensate: Technical and Diagnostic AspectsMolecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a reviewNuclear localization of leukotriene A4 hydrolase in type II alveolar epithelial cells in normal and fibrotic lungBreath tests in respiratory and critical care medicine: from research to practice in current perspectivesCough and its importance in COPDComparative analysis of selected exhaled breath biomarkers obtained with two different temperature-controlled devices.Extracellular superoxide dismutase and risk of COPD.Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD.Biomarkers in exhaled breath condensate: a review of collection, processing and analysis.Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseasesExhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?Biomarkers in breath condensate: a promising new non-invasive technique in free radical research.Effect of naturally occurring ozone air pollution episodes on pulmonary oxidative stress and inflammationTargeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment.Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?Bronchial epithelial spheroids: an alternative culture model to investigate epithelium inflammation-mediated COPD.Cigarette smoke-induced lung inflammation in COPD mediated via LTB4/BLT1/SOCS1 pathwayOxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.Pulmonary biomarkers in chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease, inflammation and PDE4 inhibitors.Collection of exhaled breath and exhaled breath condensate in veterinary medicine. A review.Histone deacetylation: an important mechanism in inflammatory lung diseases.Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stressExhaled breath condensate: a new method for lung disease diagnosis.Phosphorylation of serine 271 on 5-lipoxygenase and its role in nuclear export.Identifying targets for COPD treatment through gene expression analyses.Clinical use of exhaled biomarkers in COPD.Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.Measurement of tumor necrosis factor-alpha, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease.Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization.Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients.Airways inflammation and treatment during acute exacerbations of COPD.Potential role of leukotriene modifiers in the treatment of chronic obstructive pulmonary disease.Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications.Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis.
P2860
Q21257182-B40DABC3-5164-4781-BEB2-78B8B9CFEABAQ24798450-0FF1A902-89E1-4DBB-8DD7-DB808A8C47E6Q24811895-F6C6C4F8-75C8-4AA9-8FA8-913D17653F70Q26777960-0D37D3AB-F515-4662-B6D9-9293F692FF10Q28082250-4F22C7E2-3374-47BF-97F5-BA8BF91E3689Q28390078-EC3A615A-0133-4CD3-9AC9-87804F7725D8Q28565050-AA14B764-BB6F-431A-829A-B8C8E1191C44Q30448113-F8806F41-C5C3-45F8-B510-611A014775C0Q30488037-37DD7C7C-5F50-4A10-BFAA-B11CA6AF9780Q30931858-73A89EF5-5D23-48B3-B783-841E3E17DD3EQ33821221-FCC09408-0BB3-4ABD-90F3-5532EDC9FE25Q34274539-0C5E099A-52B4-4B35-8AED-869358D63E5CQ34684120-96ECEC02-FC10-478F-8405-46C08489092EQ34684239-454F43BD-8AE7-45DD-BAE0-EB49732E3160Q35104665-5525905B-6023-4E76-95E5-EFDA9A532740Q35296097-441CDA41-97D0-4E50-97BB-DF09C798E8F7Q35644132-065345D3-EC6E-4711-80C2-1C69C0A537EFQ35681366-DE6560FB-C0A5-420D-8924-D2EFFA382B3FQ36318525-BFDA19C7-6FD4-425B-9AE5-16145F639282Q36376519-10AAA291-0F8F-4331-A243-0C930FAD0761Q36407068-6F780F32-4B67-42F8-9B14-5C5B5D40915AQ36412757-E7A99D89-FD0A-44DB-AE78-02E34FA9231CQ36426923-8B419253-CEB0-4A26-B4D7-8C0CD4A8DB25Q36429908-DE43D9F4-E7B6-4478-BFCD-DF40EE9EF0A9Q36554689-D74FA715-8042-4587-A22A-74B73874947FQ36628503-DAB4BF06-6233-4E76-9A4A-80B45ADB49D1Q36674117-10DFA4B9-0DE5-463D-A493-67B259C42A0DQ36902161-FC167DF2-0355-4B64-BAE5-1E5B26CB7150Q36941879-350638D6-67A6-4525-A7B5-6241DCF30411Q37029845-27F8F25D-FC9C-4A43-BBBA-74843AAF3F4BQ37070343-D3128464-3F0F-41BB-A84D-454C1DF94278Q37082558-158E3B64-6F75-40BA-A23E-4C6380E1BA87Q37115894-4FC9E861-AA02-4883-94CE-1DFD1D38CABCQ37168322-2AF76223-8DB3-4698-B811-4DA9BD904182Q37178837-C8543F8F-2364-44D8-9E23-83E5CB616D72Q37216066-52198906-3FE7-4AA6-850D-9EE922F3F071Q37237665-F81FDE9D-54A1-4A20-A522-7EC5AB054716Q37254469-1C5556CD-3C17-4E4E-952C-A8AD6386E98BQ37362565-D1AF50F3-47FF-4584-8646-95AFEE8F71DBQ37741459-B2F15028-70DC-4570-BA06-1F9CE69971B1
P2860
Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Increased leukotriene B4 and 8 ...... ts with exacerbations of COPD.
@ast
Increased leukotriene B4 and 8 ...... ts with exacerbations of COPD.
@en
type
label
Increased leukotriene B4 and 8 ...... ts with exacerbations of COPD.
@ast
Increased leukotriene B4 and 8 ...... ts with exacerbations of COPD.
@en
prefLabel
Increased leukotriene B4 and 8 ...... ts with exacerbations of COPD.
@ast
Increased leukotriene B4 and 8 ...... ts with exacerbations of COPD.
@en
P2093
P2860
P356
P1433
P1476
Increased leukotriene B4 and 8 ...... ts with exacerbations of COPD.
@en
P2093
Biernacki WA
Kharitonov SA
P2860
P304
P356
10.1136/THORAX.58.4.294
P407
P577
2003-04-01T00:00:00Z